azacitidine has been researched along with Familial Nonmedullary Thyroid Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albulescu, A; Anton, G; Badiu, CV; Bostan, M; Botezatu, A; Dobrescu, R; Fudulu, A; Grancea, C; Huica, I; Iancu, IV; Manda, DA; Mihaila, M; Plesa, A; Vladoiu, SV | 1 |
| Cao, YM; Gu, J; Ji, QH; Liao, T; Qu, N; Shi, RL; Sun, GH; Wang, Y; Wang, YJ; Wei, WJ; Wen, D; Yu, J; Zhang, L; Zhang, YS; Zhao, YX; Zhu, YX | 1 |
| Hayashi, Y; Imai, T; Kikumori, T; Kiuchi, T; Kurebayashi, J; Murata, Y; Sassa, M; Watanabe, R | 1 |
| Byun, DW; Chun, SW; Jung, CH; Kang, SG; Kim, BY; Kim, CH; Kim, SJ; Kim, YJ; Ko, HJ; Mok, JO; Park, HK; Suh, KI; Yoo, MH | 1 |
4 other study(ies) available for azacitidine and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Azacitidine; Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; Dioxygenases; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Epigenesis, Genetic; Feasibility Studies; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mixed Function Oxygenases; Promoter Regions, Genetic; Proto-Oncogene Proteins; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Young Adult | 2020 |
Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
Topics: Apoptosis; Azacitidine; Carcinoma, Papillary; Cell Line, Tumor; Cell Movement; Decitabine; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Male; Mutation; Neoplasm Invasiveness; Neoplasm Staging; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyroid Neoplasms; Transcription Factors | 2018 |
Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer.
Topics: Adult; Aged; Apoptosis Regulatory Proteins; Azacitidine; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Female; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mutation; Nuclear Proteins; Promoter Regions, Genetic; Thyroid Cancer, Papillary; Thyroid Neoplasms; Trans-Activators; Transcription Factors | 2011 |
DNA methylation of RUNX3 in papillary thyroid cancer.
Topics: Azacitidine; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Core Binding Factor Alpha 3 Subunit; Decitabine; DNA Methylation; Gene Expression; Humans; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2012 |